One-Minute Clinician

| Article

As we look at the difference between interdisciplinary and integrative, it really helps to back up the train, so to speak, to see what the words actually mean. Over the years, we’ve seen progress from multidisciplinary to interdisciplinary care, and the medical home model that emphasizes how the...

| Article

“Spinal bracing” is using braces to help give people stability and pain relief in their spine, particularly in the neck and then the low back. Braces help people move. We want to change people from a focus on pain to a focus on function, and spinal bracing helps us to do that. In the old days,...

| Article

It has been suggested that stroke associated loss of inhibitory neurons in the spinothalamic tract causes disinhibition of thalamic neurons, which generate ectopic nociceptive action potentials responsible for the pain experience. However, recent data suggests that pain is dependent on the...

| Article

What scares me is our pendulum of pain management was all the way in one direction, pushing for aggressive pain management, taking that pain score without any kind of other understanding about tolerability or functionality and now we’re a little hysterical. And this pendulum has swung the other way...

| Article

I think suicide is a silent epidemic. I think we’ve been so obsessed with the “opioid crisis” that we really miss this cry for help from patients with chronic musculoskeletal or nonmalignant pain and malignant pain. Almost 50% of patients with chronic pain have suicidal thoughts, and they may not...

| Article

Primary care should know that the number of regulatory agencies that are getting involved in the management of chronic pain seems to be growing by the week. Since 2011, the Food and Drug Administration has become really involved with the post-marketing prescribing of opioids, with REMS being...

| Article

Looking at medication options for substance use disorder, there is buprenorphine which is a full mu opioid agonist and also has an affinity to the kappa receptor which is what makes it lower liability in terms of abuse. Buprenorphine has been around for a long time. In the 1980s it was an injectable...

| Article

Dr. Aljassem: In reviewing the literature with topical opioids, like many things that are kind of outside the box, a lot of it is not standardized. But what we do know is that they are effective in reducing pain and they are minimally absorbed systemically so they do have a high benefit with low...

| Article

In terms of diagnosis and treatment of neuropathic pain, we have a long way to go.  Many patients have a component of neuropathic pain to their overall pain experience that is not recognized by those taking care of them. And then often when it is recognized, it’s not treated adequately. An example...

| Article

Individual patient characteristics should guide the treatment plan. One creates a post-surgical treatment plan that is personalized. So it’s patient-specific, patient-centered, patient-focused personalized care plan. We have a world of generic drugs. We have no generic patients. Each patient is...

Subscribe to One-Minute Clinician

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.